Evidence map›Paper›PMID 36410319›Full record

ArticleThe American journal of tropical medicine and hygiene2023

Clinical Features of COVID-19, Dengue, and Influenza among Adults Presenting to Emergency Departments and Urgent Care Clinics-Puerto Rico, 2012-2021.

Joshua M Wong, Hannah R Volkman, Laura E Adams, Carene Oliveras García, Alma Martinez-Quiñones, Janice Perez-Padilla, Jorge Bertrán-Pasarell, Diego Sainz de la Peña, Rafael Tosado-Acevedo, Gilberto A Santiago and 6 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Clinical Symptom Patterns as Predictors of SARS-CoV-2 Infection in Healthcare Workers in Puerto Rico.International journal of environmental research and public health · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Population-level respiratory virus-virus interactions, Puerto Rico, 2013-2023.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
    Article
  8. Article
  9. Recommendations for dengue vaccine implementation in the elderly population.Therapeutic advances in vaccines and immunotherapy · 2025
    Review
  10. Article
  11. Article
  12. Sentinel Enhanced Dengue Surveillance System - Puerto Rico, 2012-2022.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2024
    Article
  13. Article
  14. Dengue Mimickers: Which Clinical Conditions Can Resemble Dengue Fever?Revista da Sociedade Brasileira de Medicina Tropical · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Joshua M WongCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Hannah R VolkmanCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Laura E AdamsCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Carene Oliveras GarcíaPonce Health Sciences University/Ponce Research Institute, Ponce, Puerto Rico.
Alma Martinez-QuiñonesCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Janice Perez-PadillaCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Jorge Bertrán-PasarellAuxilio Mutuo Hospital, San Juan, Puerto Rico.
Diego Sainz de la PeñaAuxilio Mutuo Hospital, San Juan, Puerto Rico.
Rafael Tosado-AcevedoCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Gilberto A SantiagoCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Jorge L Muñoz-JordánCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Brenda C Torres-VelásquezCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Olga LorenziCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Liliana Sánchez-GonzálezCenters for Disease Control and Prevention, San Juan, Puerto Rico.
Vanessa Rivera-AmillPonce Health Sciences University/Ponce Research Institute, Ponce, Puerto Rico.
Gabriela Paz-BaileyCenters for Disease Control and Prevention, San Juan, Puerto Rico.

Funding

NCEZID CDC HHS U01 CK000437NCEZID CDC HHS U01 CK000580
6 · The paper itself

Abstract

Dengue and influenza are pathogens of global concern and cause febrile illness similar to COVID-19. We analyzed data from an enhanced surveillance system operating from three emergency departments and an urgent care clinic in Puerto Rico to identify clinical features predictive of influenza or dengue compared with COVID-19. Participants with fever or respiratory symptoms and aged ≥18 years enrolled May 2012-January 2021 with dengue, influenza, or SARS-CoV-2 confirmed by reverse transcriptase polymerase chain reaction were included. We calculated adjusted odds ratios (aORs) and 95% CIs using logistic regression to assess clinical characteristics of participants with COVID-19 compared to those with dengue or influenza, adjusting for age, subregion, and days from illness onset to presentation for clinical care. Among 13,431 participants, we identified 2,643 with dengue (N = 303), influenza (N = 2,064), or COVID-19 (N = 276). We found differences in days from onset to presentation among influenza (2 days [interquartile range: 1-3]), dengue (3 days [2-4]), and COVID-19 cases (4 days [2-7]; P < 0.001). Cough (aOR: 0.12 [95% CI: 0.07-0.19]) and shortness of breath (0.18 [0.08-0.44]) were less common in dengue compared with COVID-19. Facial flushing (20.6 [9.8-43.5]) and thrombocytopenia (24.4 [13.3-45.0]) were more common in dengue. Runny nose was more common in influenza compared with COVID-19 (8.3 [5.8-12.1]). In summary, cough, shortness of breath, facial flushing, and thrombocytopenia helped distinguish between dengue and COVID-19. Although few features distinguished influenza from COVID-19, presentation > 4 days after symptom onset suggests COVID-19. These findings may assist clinicians making time-sensitive decisions regarding triage, isolation, and management while awaiting pathogen-specific testing.

Indexed as

COVID-19DengueInfluenza, HumanLeukopeniaThrombocytopeniaAdolescentAdultAmbulatory Care FacilitiesCoughDyspneaEmergency Service, HospitalHumansPuerto RicoSARS-CoV-2

Identifiers

PMID36410319
PMCPMC9833087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.